Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSA-ULTRA: Validation of PsASon Ultrasound Scores in Psoriatic Arthritis
NCT04102449Phase 4Withdrawn
- Sponsor
- Medical University of Graz
- Start
- Jul 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in psoriatic arthritis (PsA), sponsored by Medical University of Graz. Planned start Jul 2020; status: withdrawn.
02
Drugs
apremilast
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT04102449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04102449.